Loading…
S. 4220119th CongressIn committeeLatest action Apr 29, 2026Decoded by AI · checked against the record
Official title: Veterans Health Administration Novel Therapeutics Preparedness Act
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
The VA would create a new office to prepare for emerging mental health treatments, like certain psychedelic therapies, before they receive FDA approval.
50-second read · 4 questions answered below
This bill would create the Office of Novel Therapeutics inside the Veterans Health Administration to set policies, safety standards, and training for new mental health treatments under FDA review. It would also launch a program to test these treatments in real VA settings and allow certain VA medical centers to become centers of excellence for research and training. A new advisory committee of veterans, family members, and health experts would give input on patient safety and access.
This bill primarily affects veterans with conditions like PTSD, depression, substance use disorders, and traumatic brain injury. It also affects VA clinicians and staff who would be trained and certified to deliver these treatments.
If these treatments receive federal approval, the VA would already have the systems and trained staff in place to offer them to veterans. Without this preparation, there could be delays in veterans being able to access newly approved therapies.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
Latest action: — Committee on Veterans' Affairs. Hearings held.